drugset / Trial / NCT07591519
Clinical Trials of IBI3035 in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This study is a Phase I clinical trial that uses positive glucose clamping technology to evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence of IBI3035 with insulin injection (Awiqli?) after a single administration in healthy male subjects
Timeline
- Start
- 2026-05-08
- Primary completion
- 2027-07-30
- Completion
- 2027-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IBI3035 | Unknown | 1 iu/kg | Subcutaneous |
| Subject | Insulin icodec | Protein / enzyme biologic | 1 iu/kg | Subcutaneous |
Indications
No indication recorded.